NYSE:BIO.B
Bio-Rad Laboratories, Inc.
- Stock
Last Close
315.17
26/07 20:00
Market Cap
8.01B
Beta: -
Volume Today
243.33K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 474.83M - | 486.14M 2.38% | 480.61M 1.14% | 507.59M 5.61% | 559.88M 10.30% | 589.57M 5.30% | 569.17M 3.46% | 588.13M 3.33% | 597.25M 1.55% | 645.78M 8.13% | 749.92M 16.13% | |
average payables | 139.74M - | 138.56M 0.85% | 204.43M 47.54% | 288.36M 41.06% | 301.64M 4.61% | 285.64M 5.30% | 275.78M 3.45% | 324.71M 17.74% | 390.63M 20.30% | 374.38M 4.16% | 236.33M 36.87% | |
average receivables | 410.70M - | 400.15M 2.57% | 384.56M 3.90% | 381.92M 0.69% | 418.60M 9.60% | 429.00M 2.48% | 392.91M 8.41% | 406.05M 3.34% | 421.48M 3.80% | 459.09M 8.92% | 497.78M 8.43% | |
book value per share | 76.50 - | 75.67 1.08% | 85.33 12.76% | 87.87 2.97% | 98.81 12.46% | 134.59 36.21% | 192.84 43.28% | 331.90 72.11% | 458.15 38.04% | 322.82 29.54% | 299.26 7.30% | |
capex per share | -3.98 - | -4.73 18.83% | -3.88 17.81% | -4.81 23.80% | -3.88 19.27% | -4.35 12.09% | -3.30 24.12% | -3.32 0.65% | -4.05 21.86% | -3.83 5.36% | -5.36 39.96% | |
capex to depreciation | -0.77 - | -0.91 17.85% | -0.86 5.56% | -0.99 15.22% | -0.77 21.84% | -0.94 21.42% | -0.73 21.93% | -0.72 2.43% | -0.90 26.07% | -0.83 7.91% | -0.81 2.06% | |
capex to operating cash flow | -0.65 - | -0.50 22.93% | -0.61 21.93% | -0.65 7.44% | -1.11 69.42% | -0.45 58.97% | -0.22 52.68% | -0.17 20.10% | -0.18 7.02% | -0.59 219.06% | -0.42 28.82% | |
capex to revenue | -0.05 - | -0.06 17.70% | -0.06 10.53% | -0.07 21.93% | -0.05 22.14% | -0.06 6.37% | -0.04 24.81% | -0.04 8.83% | -0.04 6.37% | -0.04 1.44% | -0.06 43.98% | |
cash per share | 21.30 - | 24.16 13.42% | 27.08 12.10% | 28.67 5.85% | 25.65 10.54% | 28.50 11.13% | 37.54 31.70% | 33.48 10.80% | 29.35 12.35% | 60.31 105.49% | 55.22 8.44% | |
days of inventory on hand | 191.75 - | 172.51 10.03% | 199.31 15.53% | 206.01 3.37% | 223.18 8.33% | 200.12 10.33% | 191.73 4.19% | 205.02 6.93% | 162.94 20.53% | 212.61 30.48% | 229.76 8.07% | |
days payables outstanding | 56.81 - | 47.11 17.08% | 113.94 141.88% | 116.35 2.11% | 115.12 1.05% | 90.58 21.32% | 99.36 9.70% | 119.38 20.15% | 119.28 0.08% | 97.49 18.27% | 42.04 56.87% | |
days sales outstanding | 72.34 - | 63.37 12.39% | 70.76 11.65% | 65.71 7.13% | 78.54 19.53% | 62.66 20.22% | 62.00 1.05% | 60.14 3.00% | 52.90 12.04% | 64.43 21.80% | 68.45 6.23% | |
debt to assets | 0.13 - | 0.13 1.09% | 0.12 9.97% | 0.11 3.94% | 0.10 9.77% | 0.08 22.99% | 0.05 29.98% | 0.00 98.03% | 0.00 42.87% | 0.09 14,236.83% | 0.10 12.77% | |
debt to equity | 0.20 - | 0.20 0.25% | 0.18 12.25% | 0.17 4.05% | 0.15 11.63% | 0.11 26.29% | 0.08 30.17% | 0.00 98.14% | 0.00 43.41% | 0.12 15,378.47% | 0.14 13.00% | |
dividend yield | 0.00 - | 0.35 - | 1.57 - | 5.44 247.79% | 10.61 94.96% | |||||||
earnings yield | 0.02 - | 0.03 15.92% | 0.03 9.50% | 0.01 81.25% | 0.02 209.32% | 0.05 221.40% | 0.16 205.66% | 0.22 37.73% | 0.19 14.12% | -0.29 253.76% | -0.07 76.67% | |
enterprise value | 3.64B - | 3.50B 3.72% | 4.03B 14.88% | 5.34B 32.77% | 7.13B 33.39% | 6.94B 2.70% | 10.82B 56.02% | 16.70B 54.36% | 22.08B 32.18% | 13.29B 39.82% | 10.43B 21.49% | |
enterprise value over ebitda | 11.05 - | 11.20 1.36% | 13.00 16.08% | 19.56 50.45% | 24.66 26.10% | 18.92 23.28% | 27.75 46.64% | 29.12 4.96% | 33.97 16.63% | 20.00 41.13% | 18.11 9.45% | |
ev to operating cash flow | 20.74 - | 12.82 38.18% | 21.62 68.62% | 24.69 14.23% | 68.62 177.90% | 24.30 64.59% | 23.63 2.73% | 29.04 22.85% | 33.63 15.83% | 68.34 103.20% | 27.83 59.28% | |
ev to sales | 1.71 - | 1.61 5.59% | 1.99 23.73% | 2.58 29.64% | 3.30 27.71% | 3.03 8.22% | 4.68 54.56% | 6.56 40.17% | 7.55 15.13% | 4.74 37.23% | 3.91 17.64% | |
free cash flow per share | 2.16 - | 4.74 119.27% | 2.50 47.33% | 2.54 1.89% | -0.38 114.91% | 5.22 1,476.28% | 12.04 130.80% | 16.00 32.90% | 17.96 12.21% | 2.70 84.99% | 7.47 177.20% | |
free cash flow yield | 0.02 - | 0.04 124.82% | 0.02 54.21% | 0.01 22.49% | -0.00 111.39% | 0.02 1,514.51% | 0.03 44.84% | 0.03 15.64% | 0.02 13.43% | 0.01 73.03% | 0.02 260.99% | |
graham net net | -0.89 - | 2.09 333.80% | 3.71 77.65% | 4.14 11.82% | 2.19 47.19% | -5.04 330.45% | -18.83 273.50% | -49.39 162.24% | -88.14 78.46% | -45.65 48.22% | -40.37 11.56% | |
graham number | 68.44 - | 72.38 5.76% | 86.25 19.17% | 43.46 49.62% | 92.75 113.42% | 191.42 106.38% | 505.67 164.17% | 977.17 93.24% | 1.21K 23.96% | 940.55 22.35% | 383.30 59.25% | |
income quality | 2.26 - | 3.08 36.41% | 1.65 46.48% | 7.70 367.37% | 0.91 88.23% | 0.79 12.65% | 0.26 67.08% | 0.15 41.95% | 0.15 2.30% | -0.05 134.67% | -0.59 997.53% | |
intangibles to total assets | 0.23 - | 0.23 2.37% | 0.19 15.31% | 0.17 13.28% | 0.16 4.02% | 0.06 61.34% | 0.05 16.89% | 0.04 25.94% | 0.03 10.70% | 0.05 61.73% | 0.06 9.10% | |
interest coverage | 2.77 - | 6.78 145.04% | 7.69 13.40% | 2.42 68.46% | 5.32 119.57% | -4.53 185.17% | 9.81 316.32% | 18.80 91.67% | 315.56 1,578.62% | 12.66 95.99% | 7.76 38.69% | |
interest debt per share | 17.44 - | 15.86 9.06% | 15.68 1.15% | 15.50 1.13% | 15.41 0.63% | 15.53 0.80% | 15.52 0.07% | 1.21 92.23% | 0.42 65.12% | 41.51 9,763.03% | 43.83 5.60% | |
inventory turnover | 1.90 - | 2.12 11.15% | 1.83 13.44% | 1.77 3.26% | 1.64 7.69% | 1.82 11.52% | 1.90 4.38% | 1.78 6.48% | 2.24 25.83% | 1.72 23.36% | 1.59 7.47% | |
invested capital | 0.20 - | 0.20 0.25% | 0.18 12.25% | 0.17 4.05% | 0.15 11.63% | 0.11 26.29% | 0.08 30.17% | 0.00 98.14% | 0.00 43.41% | 0.12 15,378.47% | 0.14 13.00% | |
market cap | 3.53B - | 3.48B 1.48% | 4.05B 16.25% | 5.37B 32.60% | 7.08B 31.89% | 6.93B 2.11% | 11.04B 59.38% | 17.35B 57.14% | 22.54B 29.89% | 12.52B 44.43% | 9.43B 24.70% | |
net current asset value | 545.79M - | 560.24M 2.65% | 556.56M 0.66% | 580.78M 4.35% | 635.45M 9.41% | 436.51M 31.31% | -73.65M 116.87% | -952.84M 1,193.80% | -2.12B 122.45% | -728.44M 65.63% | -509.61M 30.04% | |
net debt to ebitda | 0.32 - | 0.07 77.40% | -0.07 195.80% | -0.08 14.37% | 0.18 322.50% | 0.02 87.82% | -0.57 2,727.06% | -1.13 99.48% | -0.71 37.40% | 1.15 262.54% | 1.74 51.24% | |
net income per share | 2.72 - | 3.08 13.06% | 3.87 25.94% | 0.96 75.35% | 3.87 305.01% | 12.10 212.71% | 58.93 387.06% | 127.86 116.97% | 142.33 11.31% | -121.79 185.57% | -21.82 82.08% | |
operating cash flow per share | 6.14 - | 9.47 54.19% | 6.38 32.59% | 7.35 15.23% | 3.50 52.35% | 9.57 173.15% | 15.34 60.35% | 19.33 25.96% | 22.01 13.87% | 6.53 70.34% | 12.84 96.63% | |
payables turnover | 6.43 - | 7.75 20.60% | 3.20 58.66% | 3.14 2.07% | 3.17 1.06% | 4.03 27.10% | 3.67 8.84% | 3.06 16.77% | 3.06 0.08% | 3.74 22.36% | 8.68 131.87% | |
receivables turnover | 5.05 - | 5.76 14.14% | 5.16 10.44% | 5.55 7.68% | 4.65 16.34% | 5.83 25.35% | 5.89 1.06% | 6.07 3.10% | 6.90 13.69% | 5.67 17.90% | 5.33 5.87% | |
research and ddevelopement to revenue | 0.10 - | 0.10 2.41% | 0.10 5.67% | 0.10 4.17% | 0.12 16.41% | 0.09 24.93% | 0.09 0.82% | 0.09 1.51% | 0.09 4.42% | 0.09 1.38% | 0.08 7.33% | |
return on tangible assets | 0.03 - | 0.03 15.02% | 0.04 9.69% | 0.01 76.76% | 0.03 264.80% | 0.07 114.90% | 0.23 237.13% | 0.30 31.77% | 0.25 18.93% | -0.28 214.97% | -0.06 80.61% | |
revenue per share | 74.61 - | 75.32 0.96% | 69.19 8.14% | 70.25 1.53% | 72.84 3.69% | 76.76 5.37% | 77.46 0.92% | 85.52 10.40% | 97.97 14.56% | 94.08 3.97% | 91.45 2.79% | |
roe | 0.04 - | 0.04 14.29% | 0.05 11.69% | 0.01 76.06% | 0.04 260.13% | 0.09 129.58% | 0.31 239.94% | 0.39 26.07% | 0.31 19.36% | -0.38 221.44% | -0.07 80.67% | |
roic | 0.04 - | 0.04 13.57% | 0.04 14.31% | 0.01 73.03% | 0.04 241.29% | -0.02 142.67% | 0.03 260.42% | 0.03 13.19% | 0.03 12.75% | 0.03 23.04% | 0.03 16.16% | |
sales general and administrative to revenue | 0.37 - | 0.37 0.70% | 0.38 1.55% | 0.39 4.66% | 0.37 5.17% | 0.36 2.66% | ||||||
shareholders equity per share | 76.50 - | 75.67 1.08% | 85.33 12.76% | 87.87 2.97% | 98.81 12.46% | 134.59 36.21% | 192.84 43.28% | 331.90 72.11% | 458.15 38.04% | 322.82 29.54% | 299.26 7.30% | |
stock based compensation to revenue | 0.01 - | 0.01 6.64% | 0.01 22.89% | 0.01 13.15% | 0.01 13.72% | 0.01 12.06% | 0.02 26.86% | 0.02 6.11% | 0.02 7.20% | 0.02 24.05% | 0.02 5.59% | |
tangible asset value | 1.40B - | 1.43B 1.98% | 1.78B 24.47% | 1.95B 9.41% | 2.25B 15.51% | 3.67B 63.14% | 5.35B 45.62% | 9.39B 75.64% | 13.07B 39.17% | 8.88B 32.06% | 8.01B 9.80% | |
tangible book value per share | 49.07 - | 49.54 0.95% | 61.01 23.15% | 66.17 8.46% | 75.88 14.67% | 123.03 62.15% | 179.12 45.58% | 315.39 76.08% | 438.00 38.87% | 298.02 31.96% | 274.13 8.02% | |
working capital | 1.26B - | 1.27B 0.73% | 1.34B 5.25% | 1.37B 2.77% | 1.47B 7.37% | 1.58B 6.82% | 1.27B 19.07% | 1.51B 18.33% | 1.31B 13.27% | 2.59B 97.93% | 2.53B 2.46% |
All numbers in USD (except ratios and percentages)